Trial intelligence / Profile preview

Effect of vasopressin on renal function in vasodilatory shock after cardiac surgery

2007-001816-22Phase 4Terminated

Sponsor
Anne Ristikankare
Start
Aug 2007
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of vasopressin in Vasoplegia, hypotension, complications of surgical procedures and 1 more, sponsored by Anne Ristikankare. Primary endpoint: Renal function after argipressin treatment. Started Aug 2007; status: terminated.

02

Drugs

vasopressin
03

Conditions

Vasoplegiahypotensioncomplications of surgical proceduresacute kidney failure (AKF)

Beyond the preview

Go deeper on 2007-001816-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001816-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call